Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:2643 |
| Name | perivascular epithelioid cell tumor |
| Definition | |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation cancer organ system cancer cardiovascular cancer vascular cancer perivascular tumor perivascular epithelioid cell tumor |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|---|---|---|---|
| TSC1 inact mut | Nab-rapamycin | perivascular epithelioid cell tumor | predicted - sensitive | detail... |
| TSC2 inact mut | Nab-rapamycin | perivascular epithelioid cell tumor | predicted - sensitive | detail... |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02494570 | Phase II | Nab-rapamycin | A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa | Completed | USA | 0 |
| NCT04741438 | Phase III | Ipilimumab + Nivolumab Pazopanib | Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype (RAR-Immune) | Unknown status | FRA | 0 |
| NCT05879185 | Phase II | Izuralimab | A Study of XmAb23104 in People With Sarcoma | Terminated | USA | 0 |
| NCT07089992 | Phase II | Pembrolizumab | A Study of Pembrolizumab in People With Ultra-Rare Sarcomas | Not yet recruiting | USA | 0 |